Takeda Canada Inks Contract With Canadian Blood Services For GLASSIA

Takeda Says FDA Approves EOHILIA To Treat Eosinophilic Esophagitis

Japan's Takeda Pharmaceutical Co. Ltd. (TAK) announced Monday that the U.S. Food and Drug Administration (FDA) has approved EOHILIA (budesonide oral suspension), the first and only FDA-approved oral therapy for people 11 years and older with eosinophilic esophagitis (EoE)1 It will be available in 2 mg/10 mL convenient, single-dose stick packs by the end of February.

RTTNews | 548 days ago

Takeda Says Japan Approves CUVITRU Subcutaneous Immunoglobulin For Patients With Agammaglobulinemia

Takeda Pharmaceutical Co. Ltd. (TAK) announced that the Japanese Ministry of Health, Labour and Welfare has approved the use of CUVITRU [Immune Globulin Subcutaneous (Human), 20% Solution] in patients aged 2 years and older with agammaglobulinemia or hypogammaglobulinemia disorders.

RTTNews | 688 days ago

Takeda Says FDA Accepts BLA For ENTYVIO For Maintenance Therapy In Crohn's Disease

Takeda Pharmaceutical Co. Ltd. (TAK) announced Wednesday that the U.S. Food and Drug Administration (FDA) has accepted for review its Biologics License Application (BLA) for the investigational subcutaneous (SC) administration of ENTYVIO (vedolizumab) for maintenance therapy in adults with moderately to severely active Crohn's disease (CD) after induction therapy with ENTYVIO intravenous (IV).

RTTNews | 700 days ago

Takeda Reports Positive Topline Results Of Phase 2b Study Of TAK-279 For Active Psoriatic Arthritis

Takeda Pharmaceutical Co. Ltd. (TAK, TKPHF.PK) announced Monday positive topline results from its randomized, double-blind, placebo-controlled, multiple-dose Phase 2b trial evaluating TAK-279, an investigational oral allosteric tyrosine kinase 2 (TYK2) inhibitor with next generation selectivity, in people with active psoriatic arthritis.

RTTNews | 702 days ago

Bay Street Likely To Open On Positive Note

Canadian stocks may open higher on Wednesday, amid continued optimism about Fed interest rate cut, and easing geopolitical tensions ahead of talks between U.S. President Donald Trump and Russian President Vladimir Putin that is scheduled to take place on Friday.

RTTNews | 46 minutes ago

U.S. Dollar Extends Fall Amid Fed Rate Cut Speculation

The U.S. dollar continued to trade lower against other major currencies in the European session on Wednesday, as the U.S. Consumer Price Index data from July has raised expectations that the Fed would lower interest rates in September.

RTTNews | 1h 11min ago

FTSE 100 Modestly Higher; Beazley Plunges Sharply

U.K. stocks are turning in a mixed performance on Wednesday with investors reacting to earnings, and awaiting fresh data and trade news for directional clues.

RTTNews | 1h 18min ago

CAC 40 Up Nearly 0.5%; Essilor Rises Sharply

French stocks are gaining some ground in positive territory on Wednesday, extending previous session's rise, amid continued optimism the Fed will reduce interest rate next month, and on slightly easing concerns about tariff after the U.S. decided to extend its pause on higher tariffs against China till November 10.

RTTNews | 2h 23min ago

EURUSD	1.16956	GBPUSD	1.35615	AUDUSD	0.6543
USDJPY	147.418	USDCAD	1.37741	USDCHF	0.80488